Please try another search
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicines in China. It offers medicines in the form of creams, ointments, tablets, capsules, pills, and solutions for reproductive health, skin health, cardiovascular, cerebrovascular, dermatology, anti-inflammatory, and other areas. The company also engages in processing and trading Chinese medicinal materials; and pharmaceutical e-commerce business. The company was founded in 2007 and is headquartered in Shantou, China.
Name | Age | Since | Title |
---|---|---|---|
Xiang Yu | 52 | - | CFO & Non-Independent Director |
Shao Fang Ke | 49 | 2019 | Managing Deputy GM & Non-Independent Director |
Xiu Qing Song | 60 | 2011 | Non-Independent Director |
Qing Guang Hu | 63 | - | Non-Independent Director |
Wei Quan Zhang | 42 | - | Employee Representative Member of the Supervisory Board |
Shaobin Ke | 44 | - | Chairman of the Board of Directors & GM |
Qiu Hua Xu | 59 | - | Member of the Supervisory Board |
Guihua Wang | 62 | 2019 | Independent Director |
Zhijin Nie | 55 | 2019 | Independent Director |
Yiyong Shen | - | 2023 | Independent Director |
Li Liu | 44 | 2019 | Independent Director |
Wei Zhu | - | 2023 | Independent Director |
Zhongxi Cai | - | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review